By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Technologiepark 4

Ghent  Zwijnaarde  9052  Belgium
Phone: 32-0-9-261-06-32 Fax: 32-0-9-261-06-28


Company News
Ablynx (ABLYF) Will Announce Its Half-Year Results For 2014 With Webcast 8/21/2014 7:50:21 AM
Ablynx (ABLYF) Awarded EU2.1 Million Grant To Support Development Of Novel Nanobodies® For Ocular Applications 8/13/2014 7:18:01 AM
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014 6:23:48 AM
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014 6:10:45 AM
Ablynx (ABLYF) Release: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The "Transparency Law") 5/20/2014 11:56:36 AM
Ablynx (ABLYF) Announces Q1 2014 Business Update 5/14/2014 9:08:29 AM
Ablynx (ABLYF), Merck & Co., Inc. (MRK) Forge Cancer Pact Worth $2.3 Billion 2/3/2014 6:56:21 AM
Ablynx (ABLYF) To Present At The 32nd Annual J.P. Morgan Healthcare Conference And To Provide An Update On Its TTP Program 1/13/2014 12:15:22 PM
Ablynx (ABLYF) Provides Business Update For The First Nine Months Of 2013 11/14/2013 9:37:59 AM
Ablynx (ABLYF) Announces Update on Anti-RSV Nanobody Programme and Receives Grant Funding for Further Development 10/31/2013 10:21:14 AM